동물 헬스케어 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for animal healthcare. The report offers a detailed assessment of key market dynamics, encompassing drivers, trends, opportunities, and challenges, providing in-depth insights into the market structure. This research publication provides exclusive data and statistics outlining the anticipated growth trajectory of the global animal healthcare market from 2024 to 2033.

Key Insights:

• Animal Healthcare Market Size (2024E): USD 42.3 Billion
• Projected Market Value (2033F): USD 60.3 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 4.0%

Animal Healthcare Market - Report Scope:

The animal healthcare market encompasses products and services aimed at enhancing the health and well-being of animals across various species, including pets, livestock, and companion animals. This market caters to veterinary clinics, hospitals, animal welfare organizations, and pet owners, offering a range of pharmaceuticals, vaccines, diagnostics, and healthcare services.

Market Growth Drivers:

The global animal healthcare market is driven by several factors, including increasing pet ownership rates, rising demand for protein-rich diets necessitating better livestock health management, and growing awareness about preventive veterinary care. Advances in veterinary pharmaceuticals, biotechnology, and diagnostics are enhancing treatment outcomes and expanding the scope of care across diverse animal species. Moreover, regulatory initiatives promoting animal welfare and healthcare standards are bolstering market growth.

Market Restraints:

Despite favorable growth prospects, the animal healthcare market faces challenges related to regulatory compliance, pricing pressures, and the complexity of disease management in diverse animal populations. Stringent regulations governing the approval and commercialization of veterinary drugs and vaccines impose significant hurdles on market entry and product development. Additionally, economic volatility and fluctuations in livestock prices impact healthcare expenditures in the agricultural sector, influencing market dynamics.

Market Opportunities:

The animal healthcare market presents significant growth opportunities driven by technological innovations, demographic shifts, and evolving consumer preferences toward premium pet care products. The integration of digital health technologies, such as telemedicine and remote monitoring platforms, enhances veterinary care accessibility and client engagement. Furthermore, the expanding role of personalized medicine in veterinary diagnostics and therapeutics fosters innovation and market expansion. Strategic partnerships, investment in research and development, and the introduction of cost-effective healthcare solutions tailored to different animal species are crucial to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the animal healthcare market globally?
• Which segments and species are driving adoption of animal healthcare products and services?
• How are technological advancements reshaping the competitive landscape of the animal healthcare market?
• Who are the key players contributing to the animal healthcare market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global animal healthcare market?

Competitive Intelligence and Business Strategy:

Leading players in the global animal healthcare market, including Zoetis Inc., Merck Animal Health, and Elanco Animal Health, focus on innovation, regulatory compliance, and strategic acquisitions to gain a competitive edge. These companies invest in R&D to develop novel pharmaceuticals, vaccines, and diagnostic solutions, addressing diverse veterinary needs and market demands. Collaborations with veterinary clinics, research institutions, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on veterinary education, disease prevention, and sustainable healthcare practices supports market growth and enhances animal health outcomes in the dynamic animal healthcare landscape.

Key Companies Profiled:

• Bayer AG
• Boehringer Ingelheim GmbH
• Virbac SA
• Zoetis, Inc.
• Hester Biosciences Ltd.
• Intas Pharmaceuticals Ltd
• Merck Animal Health
• Elanco (Eli Lilly and Company)
• Ceva Sante Animale
• Alivira Animal Health Limited
• Vetoquinol S.A.
• Zydus Animal Health
• Norbrook Laboratories Limited
• Phibro Animal Health Corporation
• Dechra Pharmaceuticals PLC
• Norbrook Laboratories, Inc

Key Segments Covered in Global Industry Research

Drugs:

• Anti-Infective Agents
• Antibiotics & Antimicrobials
• Parasiticides
• Vaccines
• Hormones & Substitutes
• Nutritional Products

Animals:

• Companion Animals
• Farm Animals

Route of Administration:

• Oral
• Parenteral
• Topical

Distribution Channel:

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Market Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption Analysis
• 4.2. Key Regulations
• 4.3. Disease Epidemiology
• 4.4. Key Industry Developments
• 4.5. PESTEL Analysis
• 4.6. Porter's Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Global Veterinary Services Market Overview
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Rising Trend of Pet Adoption
  • 5.2.2. Cost Associated with Veterinary Medications
  • 5.2.3. Introduction of Regulatory Policies
  • 5.2.4. Growing Prevalence of Zoonotic Diseases
  • 5.2.5. Increasing Demand for Animal Sourced Products
  • 5.2.6. Rising Global Consumption of Meat
  • 5.2.7. Surge in Animal Care Expenditure
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Drug
  • 6.1.2. By Animal
  • 6.1.3. By Route of Administration
  • 6.1.4. By Distribution Channel
  • 6.1.5. By Country
• 6.2. 2024 Market Scenario

7. Global Animal Healthcare Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033, By Drug

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Bn) Analysis By Drug, 2019-2023
• 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Drug, 2024-2033
  • 8.3.1. Anti-Infective Agents
    • 8.3.1.1. Antibiotics & Antimicrobials
    • 8.3.1.2. Anti-Fungal
    • 8.3.1.3. Anti-Viral
  • 8.3.2. Anti-Inflammatory & Analgesic Agents
  • 8.3.3. Parasiticides
    • 8.3.3.1. Endo-Parasiticides
    • 8.3.3.2. Ecto-Parasiticides
    • 8.3.3.3. Endectocides
  • 8.3.4. Vaccines
  • 8.3.5. Hormones & Substitutes
  • 8.3.6. Nutritional Products
  • 8.3.7. Others
• 8.4. Market Attractiveness Analysis By Drug

9. Global Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033, By Animal

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Bn) Analysis, By Animal, 2019-2023
• 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Animal, 2024-2033
  • 9.3.1. Companion Animals
    • 9.3.1.1. Cats
    • 9.3.1.2. Dogs
    • 9.3.1.3. Horse
  • 9.3.2. Farm Animals
    • 9.3.2.1. Ruminants
    • 9.3.2.2. Swine
    • 9.3.2.3. Poultry
• 9.4. Market Attractiveness Analysis By Animal

10. Global Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033, By Route of Administration

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Route of Administration, 2024-2033
  • 10.3.1. Oral
    • 10.3.1.1. Tablets/Capsules
    • 10.3.1.2. Liquids
    • 10.3.1.3. Powders/Premix
    • 10.3.1.4. Others
  • 10.3.2. Parenteral
    • 10.3.2.1. Liquids
    • 10.3.2.2. Powder for Injection
  • 10.3.3. Topical
    • 10.3.3.1. Solutions (Spot-on, Pour-on)
    • 10.3.3.2. Creams & Ointments
    • 10.3.3.3. Intramammary Preparations
    • 10.3.3.4. Others
  • 10.3.4. Others
• 10.4. Market Attractiveness Analysis By Route of Administration

11. Global Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Distribution Channel, 2024-2033
  • 11.3.1. Veterinary Hospitals
  • 11.3.2. Veterinary Clinics
  • 11.3.3. Pharmacies & Drug Stores
  • 11.3.4. Others
• 11.4. Market Attractiveness Analysis By Distribution Channel

12. Global Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
• 12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, By Region, 2024-2033
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. East Asia
  • 12.3.5. South Asia
  • 12.3.6. Oceania
  • 12.3.7. Middle East and Africa (MEA)
• 12.4. Market Attractiveness Analysis By Region

13. North America Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. U.S.
    • 13.3.1.2. Canada
  • 13.3.2. By Drug
  • 13.3.3. By Animal
  • 13.3.4. By Route of Administration
  • 13.3.5. By Distribution Channel
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Drug
  • 13.4.3. By Animal
  • 13.4.4. By Route of Administration
  • 13.4.5. By Distribution Channel
• 13.5. Market Trends
• 13.6. Drivers and Restraints - Impact Analysis
• 13.7. Key Players - Intensity Mapping
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. U.S. Animal Healthcare Market Analysis
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.1.2.1. By Drug
      • 13.8.1.2.2. By Animal
      • 13.8.1.2.3. By Route of Administration
      • 13.8.1.2.4. By Distribution Channel
  • 13.8.2. Canada Animal Healthcare Market Analysis
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.2.2.1. By Drug
      • 13.8.2.2.2. By Animal
      • 13.8.2.2.3. By Route of Administration
      • 13.8.2.2.4. By Distribution Channel

14. Latin America Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Mexico
    • 14.3.1.2. Brazil
    • 14.3.1.3. Argentina
    • 14.3.1.4. Rest of Latin America
  • 14.3.2. By Drug
  • 14.3.3. By Animal
  • 14.3.4. By Route of Administration
  • 14.3.5. By Distribution Channel
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Drug
  • 14.4.3. By Animal
  • 14.4.4. By Route of Administration
  • 14.4.5. By Distribution Channel
• 14.5. Market Trends
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Key Players - Intensity Mapping
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. Mexico Animal Healthcare Market Analysis
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Drug
      • 14.8.1.2.2. By Animal
      • 14.8.1.2.3. By Route of Administration
      • 14.8.1.2.4. By Distribution Channel
  • 14.8.2. Brazil Animal Healthcare Market Analysis
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Drug
      • 14.8.2.2.2. By Animal
      • 14.8.2.2.3. By Route of Administration
      • 14.8.2.2.4. By Distribution Channel
  • 14.8.3. Argentina Animal Healthcare Market Analysis
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.3.2.1. By Drug
      • 14.8.3.2.2. By Animal
      • 14.8.3.2.3. By Route of Administration
      • 14.8.3.2.4. By Distribution Channel

15. Europe Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Germany
    • 15.3.1.2. Italy
    • 15.3.1.3. France
    • 15.3.1.4. U.K.
    • 15.3.1.5. Spain
    • 15.3.1.6. BENELUX
    • 15.3.1.7. Russia
    • 15.3.1.8. Rest of Europe
  • 15.3.2. By Drug
  • 15.3.3. By Animal
  • 15.3.4. By Route of Administration
  • 15.3.5. By Distribution Channel
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Drug
  • 15.4.3. By Animal
  • 15.4.4. By Route of Administration
  • 15.4.5. By Distribution Channel
• 15.5. Market Trends
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Key Players - Intensity Mapping
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. Germany Animal Healthcare Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Drug
      • 15.8.1.2.2. By Animal
      • 15.8.1.2.3. By Route of Administration
      • 15.8.1.2.4. By Distribution Channel
  • 15.8.2. Italy Animal Healthcare Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Drug
      • 15.8.2.2.2. By Animal
      • 15.8.2.2.3. By Route of Administration
      • 15.8.2.2.4. By Distribution Channel
  • 15.8.3. France Animal Healthcare Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Drug
      • 15.8.3.2.2. By Animal
      • 15.8.3.2.3. By Route of Administration
      • 15.8.3.2.4. By Distribution Channel
  • 15.8.4. U.K. Animal Healthcare Market Analysis
    • 15.8.4.1. Introduction
    • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.4.2.1. By Drug
      • 15.8.4.2.2. By Animal
      • 15.8.4.2.3. By Route of Administration
      • 15.8.4.2.4. By Distribution Channel
  • 15.8.5. Spain Animal Healthcare Market Analysis
    • 15.8.5.1. Introduction
    • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.5.2.1. By Drug
      • 15.8.5.2.2. By Animal
      • 15.8.5.2.3. By Route of Administration
      • 15.8.5.2.4. By Distribution Channel
  • 15.8.6. BENELUX Animal Healthcare Market Analysis
    • 15.8.6.1. Introduction
    • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.6.2.1. By Drug
      • 15.8.6.2.2. By Animal
      • 15.8.6.2.3. By Route of Administration
      • 15.8.6.2.4. By Distribution Channel
  • 15.8.7. Russia Animal Healthcare Market Analysis
    • 15.8.7.1. Introduction
    • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.7.2.1. By Drug
      • 15.8.7.2.2. By Animal
      • 15.8.7.2.3. By Route of Administration
      • 15.8.7.2.4. By Distribution Channel

16. East Asia Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. China
    • 16.3.1.2. Japan
    • 16.3.1.3. South Korea
  • 16.3.2. By Drug
  • 16.3.3. By Animal
  • 16.3.4. By Route of Administration
  • 16.3.5. By Distribution Channel
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Drug
  • 16.4.3. By Animal
  • 16.4.4. By Route of Administration
  • 16.4.5. By Distribution Channel
• 16.5. Market Trends
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Key Players - Intensity Mapping
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. China Animal Healthcare Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Drug
      • 16.8.1.2.2. By Animal
      • 16.8.1.2.3. By Route of Administration
      • 16.8.1.2.4. By Distribution Channel
  • 16.8.2. Japan Animal Healthcare Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Drug
      • 16.8.2.2.2. By Animal
      • 16.8.2.2.3. By Route of Administration
      • 16.8.2.2.4. By Distribution Channel
  • 16.8.3. South Korea Animal Healthcare Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Drug
      • 16.8.3.2.2. By Animal
      • 16.8.3.2.3. By Route of Administration
      • 16.8.3.2.4. By Distribution Channel

17. South Asia Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Indonesia
    • 17.3.1.3. Malaysia
    • 17.3.1.4. Thailand
    • 17.3.1.5. Rest of South Asia
  • 17.3.2. By Drug
  • 17.3.3. By Animal
  • 17.3.4. By Route of Administration
  • 17.3.5. By Distribution Channel
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Drug
  • 17.4.3. By Animal
  • 17.4.4. By Route of Administration
  • 17.4.5. By Distribution Channel
• 17.5. Market Trends
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Key Players - Intensity Mapping
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. India Animal Healthcare Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Drug
      • 17.8.1.2.2. By Animal
      • 17.8.1.2.3. By Route of Administration
      • 17.8.1.2.4. By Distribution Channel
  • 17.8.2. Indonesia Animal Healthcare Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Drug
      • 17.8.2.2.2. By Animal
      • 17.8.2.2.3. By Route of Administration
      • 17.8.2.2.4. By Distribution Channel
  • 17.8.3. Malaysia Animal Healthcare Market Analysis
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Drug
      • 17.8.3.2.2. By Animal
      • 17.8.3.2.3. By Route of Administration
      • 17.8.3.2.4. By Distribution Channel
  • 17.8.4. Thailand Animal Healthcare Market Analysis
    • 17.8.4.1. Introduction
    • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.4.2.1. By Drug
      • 17.8.4.2.2. By Animal
      • 17.8.4.2.3. By Route of Administration
      • 17.8.4.2.4. By Distribution Channel

18. Oceania Animal Healthcare Market 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. Australia
    • 18.3.1.2. New Zealand
  • 18.3.2. By Drug
  • 18.3.3. By Animal
  • 18.3.4. By Route of Administration
  • 18.3.5. By Distribution Channel
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Drug
  • 18.4.3. By Animal
  • 18.4.4. By Route of Administration
  • 18.4.5. By Distribution Channel
• 18.5. Market Trends
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Key Players - Intensity Mapping
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. Australia Animal Healthcare Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Drug
      • 18.8.1.2.2. By Animal
      • 18.8.1.2.3. By Route of Administration
      • 18.8.1.2.4. By Distribution Channel
  • 18.8.2. New Zealand Animal Healthcare Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Drug
      • 18.8.2.2.2. By Animal
      • 18.8.2.2.3. By Route of Administration
      • 18.8.2.2.4. By Distribution Channel

19. Middle East and Africa (MEA) Animal Healthcare Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. GCC Countries
    • 19.3.1.2. Turkey
    • 19.3.1.3. North Africa
    • 19.3.1.4. South Africa
    • 19.3.1.5. Rest of Middle East and Africa
  • 19.3.2. By Drug
  • 19.3.3. By Animal
  • 19.3.4. By Route of Administration
  • 19.3.5. By Distribution Channel
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Drug
  • 19.4.3. By Animal
  • 19.4.4. By Route of Administration
  • 19.4.5. By Distribution Channel
• 19.5. Market Trends
• 19.6. Drivers and Restraints - Impact Analysis
• 19.7. Key Players - Intensity Mapping
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. GCC Countries Animal Healthcare Market Analysis
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Drug
      • 19.8.1.2.2. By Animal
      • 19.8.1.2.3. By Route of Administration
      • 19.8.1.2.4. By Distribution Channel
  • 19.8.2. Turkey Animal Healthcare Market Analysis
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Drug
      • 19.8.2.2.2. By Animal
      • 19.8.2.2.3. By Route of Administration
      • 19.8.2.2.4. By Distribution Channel
  • 19.8.3. South Africa Animal Healthcare Market Analysis
    • 19.8.3.1. Introduction
    • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.3.2.1. By Drug
      • 19.8.3.2.2. By Animal
      • 19.8.3.2.3. By Route of Administration
      • 19.8.3.2.4. By Distribution Channel
  • 19.8.4. North Africa Animal Healthcare Market Analysis
    • 19.8.4.1. Introduction
    • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.4.2.1. By Drug
      • 19.8.4.2.2. By Animal
      • 19.8.4.2.3. By Route of Administration
      • 19.8.4.2.4. By Distribution Channel

20. Market Structure Analysis

• 20.1. Market Analysis by Tier of Companies
• 20.2. Market Share Analysis of Top Players
• 20.3. Market Presence Analysis

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Competition Benchmarking
• 21.3. Competition Deep Dive
  • 21.3.1. Bayer AG
    • 21.3.1.1. Overview
    • 21.3.1.2. Drug Portfolio
    • 21.3.1.3. Sales Footprint
    • 21.3.1.4. Key Financials
    • 21.3.1.5. SWOT Analysis
    • 21.3.1.6. Strategy Overview
      • 21.3.1.6.1. Marketing Strategy
      • 21.3.1.6.2. Product Strategy
      • 21.3.1.6.3. Channel Strategy
  • 21.3.2. Boehringer Ingelheim GmbH
    • 21.3.2.1. Overview
    • 21.3.2.2. Drug Portfolio
    • 21.3.2.3. Sales Footprint
    • 21.3.2.4. Key Financials
    • 21.3.2.5. SWOT Analysis
    • 21.3.2.6. Strategy Overview
      • 21.3.2.6.1. Marketing Strategy
      • 21.3.2.6.2. Product Strategy
      • 21.3.2.6.3. Channel Strategy
  • 21.3.3. Virbac SA
    • 21.3.3.1. Overview
    • 21.3.3.2. Drug Portfolio
    • 21.3.3.3. Sales Footprint
    • 21.3.3.4. Key Financials
    • 21.3.3.5. SWOT Analysis
    • 21.3.3.6. Strategy Overview
      • 21.3.3.6.1. Marketing Strategy
      • 21.3.3.6.2. Product Strategy
      • 21.3.3.6.3. Channel Strategy
  • 21.3.4. Zoetis, Inc.
    • 21.3.4.1. Overview
    • 21.3.4.2. Drug Portfolio
    • 21.3.4.3. Sales Footprint
    • 21.3.4.4. Key Financials
    • 21.3.4.5. SWOT Analysis
    • 21.3.4.6. Strategy Overview
      • 21.3.4.6.1. Marketing Strategy
      • 21.3.4.6.2. Product Strategy
      • 21.3.4.6.3. Channel Strategy
  • 21.3.5. Hester Biosciences Ltd.
    • 21.3.5.1. Overview
    • 21.3.5.2. Drug Portfolio
    • 21.3.5.3. Sales Footprint
    • 21.3.5.4. Key Financials
    • 21.3.5.5. SWOT Analysis
    • 21.3.5.6. Strategy Overview
      • 21.3.5.6.1. Marketing Strategy
      • 21.3.5.6.2. Product Strategy
      • 21.3.5.6.3. Channel Strategy
  • 21.3.6. Intas Pharmaceuticals Ltd
    • 21.3.6.1. Overview
    • 21.3.6.2. Drug Portfolio
    • 21.3.6.3. Sales Footprint
    • 21.3.6.4. Key Financials
    • 21.3.6.5. SWOT Analysis
    • 21.3.6.6. Strategy Overview
      • 21.3.6.6.1. Marketing Strategy
      • 21.3.6.6.2. Product Strategy
      • 21.3.6.6.3. Channel Strategy
  • 21.3.7. Merck Animal Health
    • 21.3.7.1. Overview
    • 21.3.7.2. Drug Portfolio
    • 21.3.7.3. Sales Footprint
    • 21.3.7.4. Key Financials
    • 21.3.7.5. SWOT Analysis
    • 21.3.7.6. Strategy Overview
      • 21.3.7.6.1. Marketing Strategy
      • 21.3.7.6.2. Product Strategy
      • 21.3.7.6.3. Channel Strategy
  • 21.3.8. Elanco (Eli Lilly and Company)
    • 21.3.8.1. Overview
    • 21.3.8.2. Drug Portfolio
    • 21.3.8.3. Sales Footprint
    • 21.3.8.4. Key Financials
    • 21.3.8.5. SWOT Analysis
    • 21.3.8.6. Strategy Overview
      • 21.3.8.6.1. Marketing Strategy
      • 21.3.8.6.2. Product Strategy
      • 21.3.8.6.3. Channel Strategy
  • 21.3.9. Ceva Sante Animale
    • 21.3.9.1. Overview
    • 21.3.9.2. Drug Portfolio
    • 21.3.9.3. Sales Footprint
    • 21.3.9.4. Key Financials
    • 21.3.9.5. SWOT Analysis
    • 21.3.9.6. Strategy Overview
      • 21.3.9.6.1. Marketing Strategy
      • 21.3.9.6.2. Product Strategy
      • 21.3.9.6.3. Channel Strategy
  • 21.3.10. Alivira Animal Health Limited
    • 21.3.10.1. Overview
    • 21.3.10.2. Drug Portfolio
    • 21.3.10.3. Sales Footprint
    • 21.3.10.4. Key Financials
    • 21.3.10.5. SWOT Analysis
    • 21.3.10.6. Strategy Overview
      • 21.3.10.6.1. Marketing Strategy
      • 21.3.10.6.2. Product Strategy
      • 21.3.10.6.3. Channel Strategy
  • 21.3.11. Vetoquinol S.A.
    • 21.3.11.1. Overview
    • 21.3.11.2. Drug Portfolio
    • 21.3.11.3. Sales Footprint
    • 21.3.11.4. Key Financials
    • 21.3.11.5. SWOT Analysis
    • 21.3.11.6. Strategy Overview
      • 21.3.11.6.1. Marketing Strategy
      • 21.3.11.6.2. Product Strategy
      • 21.3.11.6.3. Channel Strategy
  • 21.3.12. Zydus Animal Health
    • 21.3.12.1. Overview
    • 21.3.12.2. Drug Portfolio
    • 21.3.12.3. Sales Footprint
    • 21.3.12.4. Key Financials
    • 21.3.12.5. SWOT Analysis
    • 21.3.12.6. Strategy Overview
      • 21.3.12.6.1. Marketing Strategy
      • 21.3.12.6.2. Product Strategy
      • 21.3.12.6.3. Channel Strategy
  • 21.3.13. Norbrook Laboratories Limited
    • 21.3.13.1. Overview
    • 21.3.13.2. Drug Portfolio
    • 21.3.13.3. Sales Footprint
    • 21.3.13.4. Key Financials
    • 21.3.13.5. SWOT Analysis
    • 21.3.13.6. Strategy Overview
      • 21.3.13.6.1. Marketing Strategy
      • 21.3.13.6.2. Product Strategy
      • 21.3.13.6.3. Channel Strategy
  • 21.3.14. Phibro Animal Health Corporation
    • 21.3.14.1. Overview
    • 21.3.14.2. Drug Portfolio
    • 21.3.14.3. Sales Footprint
    • 21.3.14.4. Key Financials
    • 21.3.14.5. SWOT Analysis
    • 21.3.14.6. Strategy Overview
      • 21.3.14.6.1. Marketing Strategy
      • 21.3.14.6.2. Product Strategy
      • 21.3.14.6.3. Channel Strategy
  • 21.3.15. Dechra Pharmaceuticals PLC
    • 21.3.15.1. Overview
    • 21.3.15.2. Drug Portfolio
    • 21.3.15.3. Sales Footprint
    • 21.3.15.4. Key Financials
    • 21.3.15.5. SWOT Analysis
    • 21.3.15.6. Strategy Overview
      • 21.3.15.6.1. Marketing Strategy
      • 21.3.15.6.2. Product Strategy
      • 21.3.15.6.3. Channel Strategy
  • 21.3.16. Norbrook Laboratories, Inc
    • 21.3.16.1. Overview
    • 21.3.16.2. Drug Portfolio
    • 21.3.16.3. Sales Footprint
    • 21.3.16.4. Key Financials
    • 21.3.16.5. SWOT Analysis
    • 21.3.16.6. Strategy Overview
      • 21.3.16.6.1. Marketing Strategy
      • 21.3.16.6.2. Product Strategy
      • 21.3.16.6.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology